- $8.62m
- $7.82m
- $4.45m
Brief: United Arab Emirates Ministry Of Health And Prevention Approves Biomerica’S Fortel® Ulcer Test For Detection Of H. Pylori Infection
Brief: Biomerica - Fortel Kidney Disease Test Approved For Sale In UAE
Brief: Biomerica Announces Reverse Stock Split
Brief: Biomerica Reports Third Quarter Fiscal 2025 Financial Results
Brief: Biomerica’S Infoods® IBS Clinical Trial Results Published And Featured In Gastroenterology, The Leading Gi Medical Journal
Brief: United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer
Brief: Biomerica Q2 Net Income USD -950 Thousand
Brief: Biomerica Secures Three Key International Patents For inFoods Technology To Address GERD, Crohn’s Disease, And Ulcerative Colitis
Brief: Nasdaq Grants Biomerica An Additional 180 Days To Meet Listing Compliance Requirements
Brief: Biomerica Reports First Quarter Fiscal 2025 Financial Results
Brief: The Saudi Food And Drug Authority Approves Biomerica's At Home PSA Screening Test To Detect Early Signs Of Prostate Cancer
Brief: Biomerica On June 26 Jack Kenny Notified Biomerica Of His Resignation As Company's Chairman Of Board
Brief: Biomerica Entered Into At Market Issuance Sales Agreement With EF Hutton, R.F. Lafferty
Brief: Biomerica And Leading UAE Healthcare Co Forge Path To Enhanced Colorectal And Breast Screening
Brief: Biomerica Provides Update On inFoods IBS Expansion
U.S. STOCKS ON THE MOVE-Biomerica, Netflix, SunPower
Biomerica surges as FDA clears bacterial infection test
Brief: Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups
Brief: Biomerica Q1 revenue USD 1.7 million